| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110925 Compositions and Methods for the Treatment and Diagnosis of Cancer |
| 05/12/2011 | US20110110923 Fish assay for eml4 and alk fusion in lung cancer |
| 05/12/2011 | US20110110921 Methods for Treating Bleeding Disorders |
| 05/12/2011 | US20110110918 Role of (de)acetylation in counteracting protein aggregation |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/12/2011 | US20110110902 Means and methods for counteracting, delaying and/or preventing heart disease |
| 05/12/2011 | US20110110863 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications |
| 05/12/2011 | US20110110860 Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter |
| 05/12/2011 | US20110110859 Protein |
| 05/12/2011 | US20110108417 Osmium Compound Useful as Redox Mediator |
| 05/12/2011 | US20110107655 Pulsed electric field (PEF) method for continuous enhanced extraction of oil and lipids from small aquatic plants |
| 05/12/2011 | DE102009052645A1 Method for conversion of first sequence of first elements of given final first quantity of physical incarnation into second sequence of second element of finite second quantity by dissecting the first element sequence in its first element |
| 05/12/2011 | DE102009052404A1 System for high throughput screening of candidate compounds, comprises a first and second type of lipid membrane vesicle, and a device for the determination of desired effect of the candidate compounds to be tested |
| 05/12/2011 | DE102009046598A1 Vorrichtung zur Durchführung von Tests, insbesondere von molekularbiologischen Tests An apparatus for performing tests, in particular molecular biological tests |
| 05/12/2011 | DE102009037011B3 Molecular lithography process for nanopattern generation in a substrate, comprises producing a mask structure with a self-styled organization, from single unbranched macromolecules with negative load |
| 05/12/2011 | DE102007013736B4 Verfahren zur Detektion von Bakterien in aus Blut abgeleiteten Proben mittels Sauerstoff-Konzentrationsbestimmung A method for detection of bacteria in blood-derived sample by means of oxygen-concentration determination |
| 05/12/2011 | DE102006046079B4 Verfahren und Kit zur Analyse des DNA-Gehalts von Zellen A method and kit for the analysis of the DNA content of cells |
| 05/12/2011 | DE102006027675B4 Verfahren zur Bestimmung der Konzentration von Nukleinsäuren A method for determining the concentration of nucleic acids |
| 05/12/2011 | CA2790153A1 Thd primer target detection |
| 05/12/2011 | CA2780436A1 Improved methods of enzymatic hydrolysis |
| 05/12/2011 | CA2780222A1 Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
| 05/12/2011 | CA2780154A1 Diagnostic assays for chordopoxviruses |
| 05/12/2011 | CA2780016A1 Size-based genomic analysis |
| 05/12/2011 | CA2779750A1 Non-invasive diagnosis of graft rejection in organ transplant patients |
| 05/12/2011 | CA2779695A1 Fetal genomic analysis from a maternal biological sample |
| 05/12/2011 | CA2779689A1 Composition and method for synthesizing a deoxyribonucleotide chain using a double stranded nucleic acid complex with a thermostable polymerase |
| 05/12/2011 | CA2779526A1 Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779281A1 Catenae: serosal cancer stem cells |
| 05/12/2011 | CA2779223A1 Molecular profiling for personalized medicine |
| 05/12/2011 | CA2778828A1 Genetic loci associated with resistance to tropical rust in maize |
| 05/12/2011 | CA2778552A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | CA2778532A1 Polynucleotide primers and probes |
| 05/12/2011 | CA2778249A1 Quantitative nuclease protection sequencing (qnps) |
| 05/12/2011 | CA2778005A1 Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer |
| 05/12/2011 | CA2778004A1 Diagnostic methods for determining prognosis of non-small-cell lung cancer |
| 05/12/2011 | CA2777169A1 Diagnostic methods for determining prognosis of non-small cell lung cancer |
| 05/11/2011 | EP2320231A2 Assays involving sam-modified colloids and non-colloidal structures |
| 05/11/2011 | EP2320230A1 Reagent for detecting abnormal cell in cervix of uterus, and method for detecting abnormal cell in cervix of uterus by using same |
| 05/11/2011 | EP2320209A1 Tissue piece forming device and tissue piece forming method |
| 05/11/2011 | EP2319943A1 Methods of predicting therapeutic efficacy of cancer therapy |
| 05/11/2011 | EP2319942A2 Method for the amplificiation of HLA class I alleles |
| 05/11/2011 | EP2319941A2 Method and apparatus for correlating levels of biomarker products with disease |
| 05/11/2011 | EP2319940A1 Primer generation rolling circle amplification |
| 05/11/2011 | EP2319939A2 Gene expression profiling of inflammatory bowel disease |
| 05/11/2011 | EP2319938A1 Method for detecting chromosome deficiencies for congenital abnormality |
| 05/11/2011 | EP2319937A1 Blood component measurement method utilizing hemolyzed whole blood, and kit for the method |
| 05/11/2011 | EP2319936A2 Yeast screens for agents affecting protein folding |
| 05/11/2011 | EP2319930A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 05/11/2011 | EP2319924A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 05/11/2011 | EP2319922A1 Nucleic acid probe set and method of using the same |
| 05/11/2011 | EP2319919A1 Nitrilases |
| 05/11/2011 | EP2319917A2 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/11/2011 | EP2319916A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 05/11/2011 | EP2319866A2 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 05/11/2011 | EP2319863A1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 05/11/2011 | EP2319861A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 05/11/2011 | EP2319857A2 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 05/11/2011 | EP2319855A1 Bioconjugation of Macromolecules |
| 05/11/2011 | EP2319854A1 Bioconjugation Of Macromolecules |
| 05/11/2011 | EP2319617A1 Arrays of microparticles and methods of preparation thereof |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319318A2 Methods of identifying compounds that target TRNA splicing endonuclease and uses of said compounds as anti-proliferative agents |
| 05/11/2011 | EP2318971A1 Prediction method for the screening, prognosis, diagnosis or therapeutic response of prostate cancer, and device for implementing said method |
| 05/11/2011 | EP2318834A2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
| 05/11/2011 | EP2318553A2 Markers for assessing the susceptibility of cancer to igf-1r treatment |
| 05/11/2011 | EP2318552A2 Methods for stratifying and annotating cancer drug treatment options |
| 05/11/2011 | EP2318551A1 System and methods for measuring biomarker profiles |
| 05/11/2011 | EP2318550A1 Gene expression profiles associated with lean phenotype and uses thereof |
| 05/11/2011 | EP2318549A2 Detecting nucleic acid |
| 05/11/2011 | EP2318548A2 Methods and systems for predicting response of cells to a therapeutic agent |
| 05/11/2011 | EP2318547A2 Methods and devices for single-molecule whole genome analysis |
| 05/11/2011 | EP2318545A1 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity |
| 05/11/2011 | EP2318544A2 Method for predicting and detecting tumor metastasis |
| 05/11/2011 | EP2318543A2 Signatures and pcdeterminants associated with prostate cancer and methods of use thereof |
| 05/11/2011 | EP2318542A1 Kit and method for evaluating detection properties in amplification reactions |
| 05/11/2011 | EP2318541A2 Methods for plant fiber characterization and identification |
| 05/11/2011 | EP2318540A1 Enzymatical modif ication of cell glycosylation using serum albumin and divalent cations |
| 05/11/2011 | EP2318539A2 Method for purifying nucleic acids from microorganisms present in liquid samples |
| 05/11/2011 | EP2318538A1 Methods of identifying modulators of ubiquiting ligases |
| 05/11/2011 | EP2318536A2 Combination of two genetic elements for the control of the flower development of a dicotyldenous plant , its application in methods of detection and selection |
| 05/11/2011 | EP2318527A1 Methods for gene targeting |
| 05/11/2011 | EP2318508A1 Determination of the integrity of rna |
| 05/11/2011 | EP2318139A2 Method and system for detection and/or characterization of a biological particle in a sample |
| 05/11/2011 | EP2318036A2 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 05/11/2011 | EP2318035A1 Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
| 05/11/2011 | EP2318028A2 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 05/11/2011 | EP2234724B1 Apparatus and method for detecting dna damage |
| 05/11/2011 | EP2203567B1 High resolution, high throughput hla genotyping by clonal sequencing |
| 05/11/2011 | EP2038415B1 Dph2 gene deletion mutant and uses thereof |
| 05/11/2011 | EP1860436B1 Blood coagulation accelerator and vessel for blood test |
| 05/11/2011 | EP1856537B1 Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism |
| 05/11/2011 | EP1813673B1 Identification marker responsive to interferon therapy for renal cell cancer |
| 05/11/2011 | EP1789796B1 Blood urea nitrogen (bun) sensor |
| 05/11/2011 | EP1774037B1 Assays and methods using biomarkers |
| 05/11/2011 | EP1725271B1 Method for deactivating nucleic acids |
| 05/11/2011 | EP1693461B1 Method of assaying glycated protein |
| 05/11/2011 | EP1678497B1 Methods and compositions for modulating apoptosis |